Shanghai Model Organisms Center Inc - Asset Resilience Ratio
Shanghai Model Organisms Center Inc (688265) has an Asset Resilience Ratio of 35.82% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Model Organisms Center Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how Shanghai Model Organisms Center Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 688265 current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Model Organisms Center Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Shanghai Model Organisms Center Inc carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥714.81 Million | 35.82% |
| Total Liquid Assets | CN¥714.81 Million | 35.82% |
Asset Resilience Insights
- Very High Liquidity: Shanghai Model Organisms Center Inc maintains exceptional liquid asset reserves at 35.82% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Model Organisms Center Inc Industry Peers by Asset Resilience Ratio
Compare Shanghai Model Organisms Center Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Abivax SA
PA:ABVX |
Biotechnology | 2.58% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Lifecome Biochemistry Co Ltd
SHE:002868 |
Biotechnology | 4.69% |
|
Pulike Biological Engineering
SHG:603566 |
Biotechnology | 17.82% |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
Biotechnology | 14.00% |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
Biotechnology | 41.67% |
|
Upstream Bio, Inc.
NASDAQ:UPB |
Biotechnology | 64.70% |
Annual Asset Resilience Ratio for Shanghai Model Organisms Center Inc (2015–2025)
The table below shows the annual Asset Resilience Ratio data for Shanghai Model Organisms Center Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 44.52% | CN¥883.15 Million ≈ $129.23 Million |
CN¥1.98 Billion ≈ $290.25 Million |
+2.52pp |
| 2024-12-31 | 42.00% | CN¥810.36 Million ≈ $118.58 Million |
CN¥1.93 Billion ≈ $282.33 Million |
-4.41pp |
| 2023-12-31 | 46.42% | CN¥927.28 Million ≈ $135.69 Million |
CN¥2.00 Billion ≈ $292.34 Million |
+9.28pp |
| 2022-12-31 | 37.14% | CN¥762.73 Million ≈ $111.61 Million |
CN¥2.05 Billion ≈ $300.52 Million |
+31.53pp |
| 2021-12-31 | 5.61% | CN¥110.25 Million ≈ $16.13 Million |
CN¥1.96 Billion ≈ $287.40 Million |
-14.01pp |
| 2020-12-31 | 19.62% | CN¥70.06 Million ≈ $10.25 Million |
CN¥357.02 Million ≈ $52.24 Million |
-20.79pp |
| 2019-12-31 | 40.41% | CN¥88.37 Million ≈ $12.93 Million |
CN¥218.70 Million ≈ $32.00 Million |
+35.91pp |
| 2015-12-31 | 4.50% | CN¥5.00 Million ≈ $731.66K |
CN¥111.16 Million ≈ $16.27 Million |
-- |
About Shanghai Model Organisms Center Inc
Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. It uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. The company offers toolbox of mice; disease mice, such as rare, infectious, a… Read more